Evidence map›Paper›PMID 25136568›Full record

SynthesisBioMed research international2014

Clinical applications of platelet-rich plasma in patellar tendinopathy.

D U Jeong, C-R Lee, J H Lee, J Pak, L-W Kang, B C Jeong, S H Lee

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Platelet Concentrates in Musculoskeletal Medicine.International journal of molecular sciences · 2020
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Tendon injury: from biology to tendon repair.Nature reviews. Rheumatology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

D U JeongSchool of Medicine, Korea University College of Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul 136-705, Republic of Korea ; National Leading Research Laboratory, Department of Biological Sciences, Myongji University, 116 Myongji-ro, Yongin, Gyeonggi-do 449-728, Republic of Korea.
C-R LeeNational Leading Research Laboratory, Department of Biological Sciences, Myongji University, 116 Myongji-ro, Yongin, Gyeonggi-do 449-728, Republic of Korea.
J H LeeNational Leading Research Laboratory, Department of Biological Sciences, Myongji University, 116 Myongji-ro, Yongin, Gyeonggi-do 449-728, Republic of Korea.
J PakStems Medical Clinic, 32-3 Chungdam-dong, Gangnam-gu, Seoul 135-950, Republic of Korea.
L-W KangDepartment of Biological Sciences, Konkuk University, 1 Hwayang-dong, Gwangjin-gu, Seoul 143-701, Republic of Korea.
B C JeongNational Leading Research Laboratory, Department of Biological Sciences, Myongji University, 116 Myongji-ro, Yongin, Gyeonggi-do 449-728, Republic of Korea.
S H LeeNational Leading Research Laboratory, Department of Biological Sciences, Myongji University, 116 Myongji-ro, Yongin, Gyeonggi-do 449-728, Republic of Korea.ORCID 0000-0002-5660-7122
Myongji University · KRKonkuk University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Platelet-rich plasma (PRP), a blood derivative with high concentrations of platelets, has been found to have high levels of autologous growth factors (GFs), such as transforming growth factor-β (TGF-β), platelet-derived growth factor (PDGF), fibroblastic growth factor (FGF), vascular endothelial growth factor (VEGF), and epidermal growth factor (EGF). These GFs and other biological active proteins of PRP can promote tissue healing through the regulation of fibrosis and angiogenesis. Moreover, PRP is considered to be safe due to its autologous nature and long-term usage without any reported major complications. Therefore, PRP therapy could be an option in treating overused tendon damage such as chronic tendinopathy. Here, we present a systematic review highlighting the clinical effectiveness of PRP injection therapy in patellar tendinopathy, which is a major cause of athletes to retire from their respective careers.

Indexed as

Blood PlateletsPlasmaTendinopathyChronic DiseaseFibrosisHumansIntercellular Signaling Peptides and ProteinsNeovascularization, PhysiologicIntercellular Signaling Peptides and Proteins

Identifiers

PMID25136568
PMCPMC4127290
OpenAlexW2095764343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.